Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Giuseppe Accogli

Giuseppe Accogli

Chief Executive Officer, Chiesi Group

Appears in 1 story

Notable Quotes

Acquiring KalVista is a transformational step for our rare disease portfolio, said Accogli in the announcement.

Stories

Chiesi acquires KalVista as pharma deepens rare disease push

Money Moves

Leading the largest deal in company history

For decades, people with hereditary angioedema had one option when an attack hit: inject themselves, often in a panic. In this genetic condition, the immune system misfires and swells tissues shut—sometimes fatally, closing the airway. In July 2025, a pill changed that.

Updated May 31